Teake Kooistra
Research Subjects
Teake Kooistra has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- J. J. Emeis
From the *Department of Cardiology, Leiden University Medical Centre, Leiden, the Netherlands; †Biomedical Research TNO, Gaubius Building, Leiden, the Netherlands; ‡Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands; and §Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
7 shared publications - Robert Kleemann
From Gaubius Laboratory (T.K., L.V., J.d.V.v.d.W., K.T., H.M.G.P., R.K.), TNO-Pharma, Leiden, The Netherlands; University of Ulm (W.K.), Department of Internal Medicine II-Cardiology, Ulm, Germany; Leiden University Medical Center (L.V., R.K.), Department of Vascular Surgery, Leiden, The Netherlands
6 shared publications P.Y. Wielinga
4 shared publicationsK Toet
3 shared publicationsL. Verschuren
3 shared publicationsM. Morrison
3 shared publications
Latest Publications
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S699-S700
P0945 : Surgical removal of inflamed epididymal white adipose tissue of obese C57BL6/J mice attenuates the development of non-alcoholic steatohepatitis
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S699-S700
P0945 : Surgical removal of inflamed epididymal white adipose tissue of obese C57BL6/J mice attenuates the development of non-alcoholic steatohepatitis
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S159
P282 ROSIGLITAZONE REDUCES ADIPOSE TISSUE INFLAMMATION AND ATTENUATES PROGRESSION OF STEATOSIS TO NASH
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S159
P282 ROSIGLITAZONE REDUCES ADIPOSE TISSUE INFLAMMATION AND ATTENUATES PROGRESSION OF STEATOSIS TO NASH
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S145-S146
P240 BILBERRY EXTRACT ATTENUATES DEVELOPMENT OF NONALCOHOLIC STEATOHEPATITIS IN ApoE3L MICE
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S145-S146
P240 BILBERRY EXTRACT ATTENUATES DEVELOPMENT OF NONALCOHOLIC STEATOHEPATITIS IN ApoE3L MICE
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S145
P239 METABOLIC SYNDROME AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ARE ATTENUATED BY INTERVENTION WITH CASPASE-1 INHIBITOR IN HIGH FAT DIET FED LDLR.LEIDEN MICE
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S145
P239 METABOLIC SYNDROME AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ARE ATTENUATED BY INTERVENTION WITH CASPASE-1 INHIBITOR IN HIGH FAT DIET FED LDLR.LEIDEN MICE
- 30 June 2009
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (2) , e248-248
Abstract: 142 HUMAN CETP AGGREVATES ATHEROSCLEROSIS BY INCREASING VLDL-CHOLESTEROL RATHER THAN BY DECREASING HDLCHOLESTEROL IN APOE*3-LEIDEN MICE
- 30 June 2009
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (2) , e248-248
Abstract: 142 HUMAN CETP AGGREVATES ATHEROSCLEROSIS BY INCREASING VLDL-CHOLESTEROL RATHER THAN BY DECREASING HDLCHOLESTEROL IN APOE*3-LEIDEN MICE
- 1 November 2000
- Vol. 84 (5) , 876-81
Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation.
Fibrin deposition, the primary step in the formation of post-surgical adhesions, is the result of a disbalance between the fibrin-forming and the fibrin-dissolving capacity of the peritoneum. Literature data suggest a transient reduction in local plasminogen activator activity after peritoneal trauma, which results in a reduction of fibrinolysis and permits deposited fibrin to become organized into fibrous, permanent adhesions. In the present study, the fibrinolytic parameters tissue-type plasminogen activator (tPA; antigen and activity) and plasminogen activator inhibitor type-1 (PAI-1; antigen and activity) were measured in peritoneal fluid, in peritoneal biopsies and in plasma to establish the time course of changes in fibrinolytic activity. A standardized peritoneal adhesion model in the rat. Analysis, over a 72-h period following surgical trauma. of the main fibrinolytic parameters in peritoneal lavage, in biopsies of damaged and undamaged peritoneum, and in plasma, and determination of fibrin and fibrin(ogen)-degradation products in peritoneal lavage fluid. At all time intervals, tPA antigen was found to be about six-fold increased in peritoneal lavage after surgical trauma. This significant rise in tPA antigen was accompanied by a large increase in its main inhibitor PAI-1, resulting in tPA activity levels similar to, or slightly higher than, those found in control animals. tPA activity was lowest at 4 h and increased thereafter. Also in biopsies from damaged peritoneum, tPA antigen was significantly increased. Tissue tPA activity was also lowest at 4 h, after which it increased, significantly so at 24 and 72 h. Similar, though smaller, changes were seen in the biopsies from undamaged areas of the peritoneal wall in operated rats. PAI-1 (antigen and activity) was not detected in peritoneal biopsies. Fibrin-related material (especially fibrin monomer/fibrinogen, an indicator of forming fibrin) in peritoneal fluid was slightly increased at 4 h, and abundantly present at 16 and 24 h, returning to control levels at 72 h. Fibrin degradation products were always present. From 2 h onward, adhesions were found. In contrast to the view that adhesions are formed as a result of a reduced fibrinolytic activity, our results demonstrate that tPA activity remained unchanged or slightly increased after surgical trauma, and point to increased fibrin formation rather than diminished fibrinolytic activity as the main cause of fibrin deposition after peritoneal trauma. Therapies directed at prevention of adhesion formation should therefore aim at avoiding massive fibrin production and at promoting fibrinolytic activity during the early period after trauma.
- 1 November 2000
- Vol. 84 (5) , 876-81
Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation.
Fibrin deposition, the primary step in the formation of post-surgical adhesions, is the result of a disbalance between the fibrin-forming and the fibrin-dissolving capacity of the peritoneum. Literature data suggest a transient reduction in local plasminogen activator activity after peritoneal trauma, which results in a reduction of fibrinolysis and permits deposited fibrin to become organized into fibrous, permanent adhesions. In the present study, the fibrinolytic parameters tissue-type plasminogen activator (tPA; antigen and activity) and plasminogen activator inhibitor type-1 (PAI-1; antigen and activity) were measured in peritoneal fluid, in peritoneal biopsies and in plasma to establish the time course of changes in fibrinolytic activity. A standardized peritoneal adhesion model in the rat. Analysis, over a 72-h period following surgical trauma. of the main fibrinolytic parameters in peritoneal lavage, in biopsies of damaged and undamaged peritoneum, and in plasma, and determination of fibrin and fibrin(ogen)-degradation products in peritoneal lavage fluid. At all time intervals, tPA antigen was found to be about six-fold increased in peritoneal lavage after surgical trauma. This significant rise in tPA antigen was accompanied by a large increase in its main inhibitor PAI-1, resulting in tPA activity levels similar to, or slightly higher than, those found in control animals. tPA activity was lowest at 4 h and increased thereafter. Also in biopsies from damaged peritoneum, tPA antigen was significantly increased. Tissue tPA activity was also lowest at 4 h, after which it increased, significantly so at 24 and 72 h. Similar, though smaller, changes were seen in the biopsies from undamaged areas of the peritoneal wall in operated rats. PAI-1 (antigen and activity) was not detected in peritoneal biopsies. Fibrin-related material (especially fibrin monomer/fibrinogen, an indicator of forming fibrin) in peritoneal fluid was slightly increased at 4 h, and abundantly present at 16 and 24 h, returning to control levels at 72 h. Fibrin degradation products were always present. From 2 h onward, adhesions were found. In contrast to the view that adhesions are formed as a result of a reduced fibrinolytic activity, our results demonstrate that tPA activity remained unchanged or slightly increased after surgical trauma, and point to increased fibrin formation rather than diminished fibrinolytic activity as the main cause of fibrin deposition after peritoneal trauma. Therapies directed at prevention of adhesion formation should therefore aim at avoiding massive fibrin production and at promoting fibrinolytic activity during the early period after trauma.
- 1 August 2000
- Vol. 84 (2) , 359-60
Oral ethinyl estradiol, but not transdermal 17beta-estradiol, increases plasma C-reactive protein levels in men.
- 1 August 2000
- Vol. 84 (2) , 359-60
Oral ethinyl estradiol, but not transdermal 17beta-estradiol, increases plasma C-reactive protein levels in men.
- 15 August 1999
- Vol. 94 (4) , 1330-6
Increased clearance explains lower plasma levels of tissue-type plasminogen activator by estradiol: evidence for potently enhanced mannose receptor expression in mice.
Several clinical studies have demonstrated an inverse relationship between circulating levels of estrogen and tissue-type plasminogen activator (t-PA). The present study was designed to test the hypothesis that estrogens lower plasma levels of t-PA by increasing its clearance from the bloodstream. 17alpha-Ethinyl estradiol (EE) treatment resulted in a significant increase in the clearance rate of recombinant human t-PA in mice (0.46 mL/min in treated mice v 0. 32 mL/min in controls; P <.01). The clearance of endogenous, bradykinin-released t-PA in rats was also significantly increased after EE treatment (area under the curve [AUC], 24.9 ng/mL. min in treated animals v 31.9 ng/mL. min in controls; P <.05). Two distinct t-PA clearance systems exist in vivo: the low-density lipoprotein receptor-related protein (LRP) on liver parenchymal cells and the mannose receptor on mainly liver endothelial cells. Inhibition of LRP by intravenous injection of receptor-associated protein (RAP) as a recombinant fusion protein with Salmonella japonicum glutathione S-transferase (GST) significantly retarded t-PA clearance in control mice (from 0.41 to 0.25 mL/min; n = 5, P <.001) and EE-treated mice (from 0.66 to 0.35 mL/min; n = 5, P <.005), but did not eliminate the difference in clearance capacity between the 2 experimental groups. Similar results were obtained in mice in which LRP was inhibited via overexpression of the RAP gene in liver by adenoviral gene transduction. In contrast, administration of mannan, a mannose receptor antagonist, resulted in identical clearances (0.22 mL/min in controls and 0.24 mL/min in EE-treated mice). Northern blot analysis showed a 6-fold increase in mannose receptor mRNA expression in the nonparenchymal liver cells of EE-treated mice, whereas the parenchymal LRP mRNA levels remained unchanged. These findings were confirmed at the protein level by ligand blotting and Western blotting analysis. Our results demonstrate that EE treatment results in increased plasma clearance rate of t-PA via induction of the mannose receptor and could explain for the inverse relationship between estrogen status and plasma t-PA concentrations as observed in humans.
- 15 August 1999
- Vol. 94 (4) , 1330-6
Increased clearance explains lower plasma levels of tissue-type plasminogen activator by estradiol: evidence for potently enhanced mannose receptor expression in mice.
Several clinical studies have demonstrated an inverse relationship between circulating levels of estrogen and tissue-type plasminogen activator (t-PA). The present study was designed to test the hypothesis that estrogens lower plasma levels of t-PA by increasing its clearance from the bloodstream. 17alpha-Ethinyl estradiol (EE) treatment resulted in a significant increase in the clearance rate of recombinant human t-PA in mice (0.46 mL/min in treated mice v 0. 32 mL/min in controls; P <.01). The clearance of endogenous, bradykinin-released t-PA in rats was also significantly increased after EE treatment (area under the curve [AUC], 24.9 ng/mL. min in treated animals v 31.9 ng/mL. min in controls; P <.05). Two distinct t-PA clearance systems exist in vivo: the low-density lipoprotein receptor-related protein (LRP) on liver parenchymal cells and the mannose receptor on mainly liver endothelial cells. Inhibition of LRP by intravenous injection of receptor-associated protein (RAP) as a recombinant fusion protein with Salmonella japonicum glutathione S-transferase (GST) significantly retarded t-PA clearance in control mice (from 0.41 to 0.25 mL/min; n = 5, P <.001) and EE-treated mice (from 0.66 to 0.35 mL/min; n = 5, P <.005), but did not eliminate the difference in clearance capacity between the 2 experimental groups. Similar results were obtained in mice in which LRP was inhibited via overexpression of the RAP gene in liver by adenoviral gene transduction. In contrast, administration of mannan, a mannose receptor antagonist, resulted in identical clearances (0.22 mL/min in controls and 0.24 mL/min in EE-treated mice). Northern blot analysis showed a 6-fold increase in mannose receptor mRNA expression in the nonparenchymal liver cells of EE-treated mice, whereas the parenchymal LRP mRNA levels remained unchanged. These findings were confirmed at the protein level by ligand blotting and Western blotting analysis. Our results demonstrate that EE treatment results in increased plasma clearance rate of t-PA via induction of the mannose receptor and could explain for the inverse relationship between estrogen status and plasma t-PA concentrations as observed in humans.